RecruitingEarly Phase 1NCT07429916

Ketamine for Shoulder Pain Following Laparoscopic Gastric Sleeve Surgery

The Role of Intraoperative Ketamine Usage as Part of Anesthetic Management in Decreasing the Incidence of Shoulder Pain Following Laparoscopic Gastric Sleeve Surgery


Sponsor

King Abdullah University Hospital

Enrollment

50 participants

Start Date

Jan 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Shoulder pain is a well-recognized complaint following laparoscopic surgery. It is underlying mechanism has various causes, therefore, modalities in management and prevention of this sort of pain are numerous with different success rates. In the light of this, the investigators aim to compare an anesthetic management plan involving using ketamine (which is a known intraoperative anesthetic agent) to another not involving it for participants undergoing gastric sleeve, and compare the incidence and intensity of shoulder pain afterwards.


Eligibility

Min Age: 18 YearsMax Age: 60 Years

Inclusion Criteria4

  • patients aged 18-60
  • American society of anesthesiologist grade 1,2
  • BMI \> 40
  • BMI \> 35 with obesity-related comorbidities

Exclusion Criteria4

  • mentally incapacitated
  • patients received any type of analgesia 24hr preoperatively except paracetamol
  • history of drug abuse
  • patients with low ejection fraction

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGIntraoperative ketamine

intra-operative intravenous ketamine infusion in a dose of 0.3mg/kg/hour


Locations(1)

King Abdullah University Hospital

Irbid, Jordan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07429916


Related Trials